PreveCeutical Medical Inc.
PRVCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14 | $13 | $13 | $10 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $4 | $4 | $3 | $3 |
| Enterprise Value | $19 | $17 | $16 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.002 | -0.003 | -0.003 |
| % Growth | 8.3% | 14.3% | 17.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |